TREATMENT PATTERN AND DISEASE BURDEN OF SEVERE ASTHMA: A REAL-WORLD STUDY BASED ON CLAIMS DATA IN CHINA

被引：0
|
作者：
Zhang, K. [1 ]
He, X. [2 ]
Wu, J. [2 ]
机构：
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 12, Peoples R China
[2] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD177
引用
下载
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [31] Real-world treatment patterns of benralizumab therapy for patients with severe asthma
    Gendron, Alain
    Sriskandarajah, Niroshan
    Johnston, Karissa
    Osenenko, Kathy M.
    Noorduyn, Stephen G.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [32] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Carlos A. Torres-Duque
    Jaime Ocampo-Gómez
    Mauricio Morales Castillo
    Diana Cano-Rosales
    Ángela Giraldo-Montoya
    Freddy Rodríguez
    Isabel Palacios-Ortega
    Mauricio Durán-Silva
    Humberto Reynales
    Elizabeth García
    BMC Pulmonary Medicine, 22
  • [33] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Torres-Duque, Carlos A.
    Ocampo-Gomez, Jaime
    Castillo, Mauricio Morales
    Cano-Rosales, Diana
    Giraldo-Montoya, Angela
    Rodriguez, Freddy
    Palacios-Ortega, Isabel
    Duran-Silva, Mauricio
    Reynales, Humberto
    Garcia, Elizabeth
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [34] REAL-WORLD TREATMENT PATTERN AND DIRECT MEDICAL COSTS OF ATOPIC DERMATITIS IN CHINA: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Wang, L.
    Zhang, J.
    He, X.
    Wu, J.
    VALUE IN HEALTH, 2022, 25 (01) : S266 - S266
  • [35] Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
    Jud, Sebastian M.
    Brendle-Behnisch, Anne
    Hack, Carolin C.
    Preuss, Caroline
    Arkudas, Andreas
    Horch, Raymund E.
    Beckmann, Matthias W.
    Lux, Michael P.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) : 521 - 531
  • [36] Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
    Sebastian M. Jud
    Anne Brendle-Behnisch
    Carolin C. Hack
    Caroline Preuss
    Andreas Arkudas
    Raymund E. Horch
    Matthias W. Beckmann
    Michael P. Lux
    Archives of Gynecology and Obstetrics, 2021, 303 : 521 - 531
  • [37] Real-world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis
    Yoshikawa, Mamoru
    Sunaga, Yoshinori
    Koshiba, Ryuji
    Inukai, Miho
    Takeuchi, Makiko
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2023, 8 (02): : 346 - 356
  • [38] Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR)
    Lee, Ji-Hyang
    Kim, Hyo-Jung
    Park, Chan Sun
    Park, So Young
    Park, So-Young
    Lee, Hyun
    Kim, Sang-Heon
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (04) : 412 - 423
  • [39] Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment from the Korean Severe Asthma Registry (KoSAR)
    Lee, J.
    Kim, H.
    Park, C. S.
    Park, S. Y.
    Park, S.
    Lee, H.
    Kim, S.
    Cho, Y. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Real-World Treatment Patterns, Outcomes and Disease Burden of Japanese Patients with High-Risk Myelodysplastic Syndrome: A Claims Database Study
    Obara, Naoshi
    Shioi, Hirotomo
    Ooi, Shi Hong
    Tay, Hao Zhe
    Wong, Tze Fang
    BLOOD, 2022, 140 : 12327 - 12328
12345